ÂÜÀòÂÒÂ×

Sari von Reedtz has over 25 years of work experience in the field of clinical research and operations. Sari is currently serving as the Clinical Operations Lead at Calliditas Therapeutics AB since December 2020. Prior to this, they worked as a Clinical Operations Manager at Maquet Getinge Group from March 2018 to December 2020.

Sari has a vast experience in managing clinical development activities for protein drugs for the treatment of orphan diseases. Sari served as a Clinical Program Leader at Sobi - Swedish Orphan Biovitrum AB (publ) from May 2012 to March 2018. Sari'sresponsibilities included establishing development plans to reach marketing authorization in the EU and US, as well as regulatory interactions with scientific advise, DSUR/PSUR updates, and EMA Type II variations.

Before joining Sobi, Sari worked as a Project Manager at A+ Sciences AB, Outsourcing from August 2009 to May 2012, where they managed clinical trials in Phase I-IV outsourced to customers. Prior to that, they worked as a Medical Writer at Quintiles from March 2005 to July 2009, authoring clinical study protocols and reports and managing the Clean File process.

Sari also gained experience as a Clinical Research Manager at AstraZeneca R&D from March 2004 to February 2005 and as a Project Manager at Quintiles AB from September 2002 to February 2004. In their role as a Project Manager at Quintiles AB, they managed study team members and activities, serving as a focal point for communication between the CRO and the sponsor.

Earlier in their career, Sari served as a Clinical Research Manager, Clinical Pharmacology at Pharmacia AB from February 1999 to December 2000. Sari'sresponsibilities included managing Phase I studies, study design, writing study protocols and reports, performing pharmacokinetic calculations, and managing study team members and project timelines.

Sari began their career as a Clinical Project Management Associate, Growth Hormone at Eli Lilly & Company from September 1998 to January 1999, where they set up a multinational Post Marketing Surveillance Program. Prior to that, they worked as a Clinical Research Associate at Eli Lilly Sweden AB from February 1996 to August 1998, conducting Phase II and Phase IV studies within Sweden.

Overall, Sari von Reedtz has demonstrated expertise in clinical operations, project management, regulatory interactions, and protocol development throughout their extensive work experience in the pharmaceutical industry.

Sari von Reedtz attended Uppsala University from 1990 to 1994, where they obtained their Master of Science degree in Pharmacy.